Publication | Closed Access

Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC)

Increased Oral BioavailabilityNanomedicineHonokiol Nanomicellar FormulationMedicinePharmacologyNano-drug DeliveryTumor TargetingAnti-cancer AgentOncologyRadiation OncologyTumor MicroenvironmentAnticancer Effects